{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:10:15Z","timestamp":1790028615223,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02410-2","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:16:22Z","timestamp":1780629382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3900-3204","authenticated-orcid":false,"given":"Soohyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-3984","authenticated-orcid":false,"given":"Mi-Kyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-497X","authenticated-orcid":false,"given":"Heui-Soo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1364-1969","authenticated-orcid":false,"given":"Mi Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-8503","authenticated-orcid":false,"given":"Soo-Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-2469","authenticated-orcid":false,"given":"Hong-Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-449X","authenticated-orcid":false,"given":"Woo-Seok","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-1346","authenticated-orcid":false,"given":"Min Kyung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9108-8527","authenticated-orcid":false,"given":"Young-Eun","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-9400","authenticated-orcid":false,"given":"Byung-Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-3763","authenticated-orcid":false,"given":"Soo-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"4","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C et al (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381","journal-title":"Lancet Neurol"},{"key":"2410_CR2","doi-asserted-by":"publisher","unstructured":"KangM-K, Cho S, Kim B-K, Moon H-S, Lee MJ, Kim S-K et al (2025) Injection-based therapies for migraine in older adults: a narrative review of OnabotulinumtoxinA, greater occipital nerve block, and anti-calcitonin gene-related peptide monoclonal antibodies. J Korean Med Sci;40(38) :e297. https:\/\/doi.org\/10.3346\/jkms.2025.40.e297","DOI":"10.3346\/jkms.2025.40.e297"},{"issue":"9","key":"2410_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/0333102409355601","volume":"30","author":"T Victor","year":"2010","unstructured":"Victor T, Hu X, Campbell J, Buse D, Lipton R (2010) Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 30(9):1065\u20131072","journal-title":"Cephalalgia"},{"issue":"5","key":"2410_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343\u2013349","journal-title":"Neurology"},{"issue":"10","key":"2410_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1474-4422(23)00206-5","volume":"22","author":"SS Hugger","year":"2023","unstructured":"Hugger SS, Do TP, Ashina H, Goicochea MT, Jenkins B, Sacco S et al (2023) Migraine in older adults. Lancet Neurol 22(10):934\u2013945","journal-title":"Lancet Neurol"},{"issue":"5","key":"2410_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3988\/jcn.2025.0036","volume":"21","author":"KM Park","year":"2025","unstructured":"Park KM, Wi JH, Lee DA, Lee HJ, Park BS, Kim J (2025) Association Between Small Vessel Disease and Migraine: A Study Based on Peak Width of Skeletonized Mean Diffusivity. J Clin Neurol 21(5):456\u2013463","journal-title":"J Clin Neurol"},{"issue":"6","key":"2410_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0333102414547138","volume":"35","author":"Z Hepp","year":"2015","unstructured":"Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB (2015) Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 35(6):478\u2013488","journal-title":"Cephalalgia"},{"issue":"1","key":"2410_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.62087\/hpr.2024.0019","volume":"26","author":"B-S Kim","year":"2025","unstructured":"Kim B-S, Chung P-W, Chung JM, Park K-Y, Moon H-S, Park H-K et al (2025) Evidence-Based Recommendations on Pharmacologic Treatment for Migraine Prevention: A Clinical Practice Guideline from the Korean Headache Society. Headache Pain Res 26(1):5\u201320","journal-title":"Headache Pain Res"},{"issue":"3","key":"2410_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jamaneurol.2023.5549","volume":"81","author":"CL Petersen","year":"2024","unstructured":"Petersen CL, Hougaard A, Gaist D, Hallas J (2024) Risk of stroke and myocardial infarction among initiators of triptans. JAMA neurol 81(3):248\u2013254","journal-title":"JAMA neurol"},{"issue":"3","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.62087\/hpr.2025.0019","volume":"26","author":"H-S Moon","year":"2025","unstructured":"Moon H-S, Chung P-W (2025) The Hidden Risks of Medication Underuse in Migraine Progression. Headache Pain Res 26(3):209\u2013217","journal-title":"Headache Pain Res"},{"issue":"22","key":"2410_CR11","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","volume":"377","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Reuter U, Hallstr\u00f6m Y, Broessner G, Bonner JH, Zhang F et al (2017) A controlled trial of erenumab for episodic migraine. NEJM 377(22):2123\u20132132","journal-title":"NEJM"},{"issue":"1","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10194-023-01585-2","volume":"24","author":"A Mu\u00f1oz-Vendrell","year":"2023","unstructured":"Mu\u00f1oz-Vendrell A, Campoy S, Caronna E, Alpuente A, Torres-Ferrus M, Nieves Castellanos C et al (2023) Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients. J Headache Pain 24(1):63","journal-title":"J Headache Pain"},{"issue":"2","key":"2410_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jamaneurol.2024.4537","volume":"82","author":"S Yang","year":"2025","unstructured":"Yang S, Orlova Y, Park H, Smith SM, Guo Y, Chapin BA et al (2025) Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. JAMA neurol 82(2):132\u2013141","journal-title":"JAMA neurol"},{"issue":"1","key":"2410_CR14","doi-asserted-by":"publisher","first-page":"e200373","DOI":"10.1212\/CPJ.0000000000200373","volume":"15","author":"A Salim","year":"2025","unstructured":"Salim A, Biswas S, Sonneborn C, Hogue O, Hennessy E, Mays M et al (2025) Efficacy and tolerability of anti-cgrp monoclonal antibodies in patients aged\u2009\u2265\u200965 years with daily or nondaily migraine. Neurol Clin Pract 15(1):e200373","journal-title":"Neurol Clin Pract"},{"key":"2410_CR15","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"2410_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/pm\/pnad141","volume":"25","author":"A Gonzalez-Martinez","year":"2024","unstructured":"Gonzalez-Martinez A, Sanz-Garc\u00eda A, Garc\u00eda-Azor\u00edn D, Rodr\u00edguez-Vico J, Jaimes A, G\u00f3mez Garc\u00eda A et al (2024) Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study. Pain Med 25(3):194\u2013202","journal-title":"Pain Med"},{"issue":"11","key":"2410_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1212\/WNL.0000000000207292","volume":"101","author":"P Barbanti","year":"2023","unstructured":"Barbanti P, Aurilia C, Egeo G, Torelli P, Proietti S, Cevoli S et al (2023) Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter Prospective Observational Study. Neurology 101(11):482\u2013488","journal-title":"Neurology"},{"issue":"3","key":"2410_CR18","doi-asserted-by":"publisher","first-page":"033310242412381","DOI":"10.1177\/03331024241238153","volume":"44","author":"F Porreca","year":"2024","unstructured":"Porreca F, Navratilova E, Hirman J, van den Brink AM, Lipton RB, Dodick DW (2024) Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia 44(3):03331024241238153","journal-title":"Cephalalgia"},{"issue":"3","key":"2410_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102417739584","volume":"39","author":"A Labastida-Ram\u00edrez","year":"2019","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Villal\u00f3n CM, MaassenVanDenBrink A (2019) Gender aspects of CGRP in migraine. Cephalalgia 39(3):435\u2013444","journal-title":"Cephalalgia"},{"issue":"22","key":"2410_CR20","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1523\/JNEUROSCI.0364-19.2019","volume":"39","author":"A Avona","year":"2019","unstructured":"Avona A, Burgos-Vega C, Burton MD, Akopian AN, Price TJ, Dussor G (2019) Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models. J Neurosci 39(22):4323\u20134331","journal-title":"J Neurosci"},{"issue":"2","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.62087\/hpr.2024.0020","volume":"25","author":"S-J Cho","year":"2024","unstructured":"Cho S-J (2024) When should headache specialists hold a needle? The role of botulinum toxin injections and occipital nerve blocks. Headache Pain Res 25(2):73\u201374","journal-title":"Headache Pain Res"},{"issue":"3","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.62087\/hpr.2025.0012","volume":"26","author":"S Cho","year":"2025","unstructured":"Cho S, Chang K (2025) Gepants for Migraine: An Update on Long-Term Outcomes and Safety Profiles. Headache Pain Res 26(3):184\u2013192","journal-title":"Headache Pain Res"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02410-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02410-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:57:06Z","timestamp":1782889026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02410-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02410-2","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB) of Uijeongbu Eulji Medical Center (IRB No. UEMC 2024-12-007-001) and the ethics committees of all other participating multicenter institutions. Given the retrospective design, the requirement for informed consent was waived, and all patient data were anonymized. The study adhered to the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}